OTHER GROUP COMPANIES
market

Zydus Lifesciences standalone net profit declines 46.87% in the March 2022 quarter

Sales decline 1.56% to Rs 1919.20 crore

May 20, 2022 2:17 IST | capital market
Net profit of Zydus Lifesciences declined 46.87% to Rs 246.90 crore in the quarter ended March 2022 as against Rs 464.70 crore during the previous quarter ended March 2021. Sales declined 1.56% to Rs 1919.20 crore in the quarter ended March 2022 as against Rs 1949.70 crore during the previous quarter ended March 2021. For the full year,net profit declined 41.88% to Rs 857.90 crore in the year ended March 2022 as against Rs 1476.20 crore during the previous year ended March 2021. Sales rose 2.06% to Rs 7590.00 crore in the year ended March 2022 as against Rs 7436.70 crore during the previous year ended March 2021.
ParticularsQuarter EndedYear Ended
?Mar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.
Sales1919.201949.70 -2 7590.007436.70 2
OPM %23.8430.46 -25.2731.04 -
PBDT469.30556.80 -16 1961.902327.10 -16
PBT346.50441.80 -22 1483.201876.00 -21
NP246.90464.70 -47 857.901476.20 -42
Powered by Capital Market - Live News

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity